Position in ARTL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$100,435
New position
Shares Held
13,250
first reported quarter
Ownership
0.568%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 9 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kathmere Capital Management, LLC holds $1,009,558 across 7 Biotechnology names. ARTL ranks #5 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SXTP |
60 Degrees Pharmaceuticals, Inc.
|
144,683 | $253,195 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
489 | $218,358 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
29,779 | $190,287 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
11,243 | $166,621 | |
| 5 | ARTL |
Artelo Biosciences, Inc.
This page
|
13,250 | $100,435 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
15,071 | $51,241 | |
| 7 | BDTX |
Black Diamond Therapeutics, Inc.
|
13,813 | $29,421 |
All Filings in ARTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,435 | 13,250 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||